These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


199 related items for PubMed ID: 19226652

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Predictive models for drugs exhibiting negative food effects based on their biopharmaceutical characteristics.
    Marasanapalle VP, Crison JR, Devarakonda KR, Li X, Jasti BR.
    Drug Dev Ind Pharm; 2011 Dec; 37(12):1429-38. PubMed ID: 21615244
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Viscosity-mediated negative food effect on oral absorption of poorly-permeable drugs with an absorption window in the proximal intestine: In vitro experimental simulation and computational verification.
    Cvijić S, Parojčić J, Langguth P.
    Eur J Pharm Sci; 2014 Sep 30; 61():40-53. PubMed ID: 24751672
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of fasted and fed state simulated and human intestinal fluids as solvent system in the Ussing chambers model to explore food effects on intestinal permeability.
    Wuyts B, Riethorst D, Brouwers J, Tack J, Annaert P, Augustijns P.
    Int J Pharm; 2015 Jan 30; 478(2):736-44. PubMed ID: 25510602
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Predicting pharmacokinetic food effects using biorelevant solubility media and physiologically based modelling.
    Jones HM, Parrott N, Ohlenbusch G, Lavé T.
    Clin Pharmacokinet; 2006 Jan 30; 45(12):1213-26. PubMed ID: 17112297
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of simulated intestinal fluid for Caco-2 permeability assay of lipophilic drugs.
    Fossati L, Dechaume R, Hardillier E, Chevillon D, Prevost C, Bolze S, Maubon N.
    Int J Pharm; 2008 Aug 06; 360(1-2):148-55. PubMed ID: 18539418
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A modified physiological BCS for prediction of intestinal absorption in drug discovery.
    Zaki NM, Artursson P, Bergström CA.
    Mol Pharm; 2010 Oct 04; 7(5):1478-87. PubMed ID: 20734997
    [Abstract] [Full Text] [Related]

  • 18. Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution/permeation system reflecting the gastric dissolution process.
    Kataoka M, Fukahori M, Ikemura A, Kubota A, Higashino H, Sakuma S, Yamashita S.
    Eur J Pharm Biopharm; 2016 Apr 04; 101():103-11. PubMed ID: 26873006
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A review of drug solubility in human intestinal fluids: implications for the prediction of oral absorption.
    Augustijns P, Wuyts B, Hens B, Annaert P, Butler J, Brouwers J.
    Eur J Pharm Sci; 2014 Jun 16; 57():322-32. PubMed ID: 23994640
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.